Rapid and inexpensive purification of adenovirus vectors using an optimised aqueous two-phase technology

Adenoviruses (AdVs) are used as gene therapy vectors to treat human diseases and as vaccines against COVID-19. AdVs are produced by transfecting human embryonic kidney 239 (HEK293) or PER.C6 virus producer cells with AdV plasmid vectors or infecting these cells withcell lysates containing replicatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Suleman, Saqlain, Schrubaji, Kuteiba, Filippou, Chrysovalanto, Ignatova, Svetlana, Hewitson, Peter, Huddleston, Jonathan, Karda, Rajvinder, Waddington, Simon N., Themis, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757833/
https://www.ncbi.nlm.nih.gov/pubmed/34626684
http://dx.doi.org/10.1016/j.jviromet.2021.114305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757833/
https://www.ncbi.nlm.nih.gov/pubmed/34626684
http://dx.doi.org/10.1016/j.jviromet.2021.114305

Ejemplares similares